630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study

Authors :: Salvatore Grisanti
Vivek Subbiah
Eric Baudin
Gedske Daugaard
Alfredo Berruti
Jennifer Martinez
Camilo Jimenez
Harm Haak
Jerome Kervevan
Lucie Aubergeon
Chloé Ventujol
Christophe Bonny
Laurent Chene
Joao Gamelas Magalhaes
CWillemien Menke-vander Houven van Oordt
Martin Fassnacht
Jaume Capdevila
Christelle de la Fouchardière
Dan Granberg
Matthias Kroiss
Hélène Toussaint
Camille Belyn
Jean-Michel Paillarse
Source :: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Publication Year :: 2023
Publisher :: BMJ Publishing Group, 2023.

Subjects :: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools